메뉴 건너뛰기




Volumn 23, Issue 4, 2005, Pages 933-934

Update on design of the national surgical adjuvant breast and bowel project trial R-04 [14]

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; TEGAFUR; URACIL;

EID: 14144255327     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.214     Document Type: Letter
Times cited : (5)

References (5)
  • 1
    • 4143143285 scopus 로고    scopus 로고
    • Substitution of oral fluoropyrimidines for infusional fluorouracil with radiotherapy: How much data do we need?
    • Crane CH, Sargent DJ: Substitution of oral fluoropyrimidines for infusional fluorouracil with radiotherapy: How much data do we need? J Clin Oncol 22:2978-2981, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 2978-2981
    • Crane, C.H.1    Sargent, D.J.2
  • 2
    • 4143132330 scopus 로고    scopus 로고
    • Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years' follow-up
    • Fernández-Martos C, Aparicio J, Bosch C, et al: Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years' follow-up. J Clin Oncol 22:3016-3022, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 3016-3022
    • Fernández-Martos, C.1    Aparicio, J.2    Bosch, C.3
  • 3
    • 9444277494 scopus 로고    scopus 로고
    • Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum
    • abstr 3505, 246s
    • Roh MS, Colangelo L, Wieand S, et al: Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum. Proc Am Soc Clin Oncol 22:246s, 2004 (abstr 3505)
    • (2004) Proc Am Soc Clin Oncol , vol.22
    • Roh, M.S.1    Colangelo, L.2    Wieand, S.3
  • 4
    • 4444377696 scopus 로고    scopus 로고
    • Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): Efficacy results of a phase III trial
    • abstr 3509, 247s
    • Cassidy J, Scheithauer W, McKendrick J, et al: Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): efficacy results of a phase III trial. Proc Am Soc Clin Oncol 22:247s, 2004 (abstr 3509)
    • (2004) Proc Am Soc Clin Oncol , vol.22
    • Cassidy, J.1    Scheithauer, W.2    McKendrick, J.3
  • 5
    • 0347352358 scopus 로고    scopus 로고
    • German Rectal Cancer Group: Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer-First results of the German Rectal Cancer Study (CAO/ARO/AIO-94)
    • suppl 2
    • Sauer R: German Rectal Cancer Group: Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer-First results of the German Rectal Cancer Study (CAO/ARO/AIO-94). Int J Radiat Oncol Biol Phys 57:3124-5125, 2003 (suppl 2)
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , pp. 3124-5125
    • Sauer, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.